In concordance, the identified SLC3A2 peptides (online supplemental figure S2) were demonstrated at significantly higher levels in melanoma vs normal skin (p<0.05, data from three normal skin and two melanoma samples tested twice each in two independent experiments) (figure 2C). Here, SLC3A2 is linked to melanoma.